Log in
Enquire now

List of Contrafect patents

List of Contrafect patents
List of Checkfree patents
List of UV Partners, Inc. patents
List of Veveo patents
HRTech venture capital investors
List of SBIR/STTR awards granted to CONSENSUS PHARMACEUTICALS, INC.
Patents where
Current Assignee
Name
is
ContrafectContrafect
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11357833 Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
11357833
June 14, 2022
‌
US Patent 11524046 Biofilm prevention, disruption and treatment with bacteriophage lysin

Patent 11524046 was granted and assigned to Contrafect on December, 2022 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
11524046
December 13, 2022
‌
US Patent 11413334 Lysin polypeptides active against Gram-negative bacteria

Patent 11413334 was granted and assigned to Contrafect on August, 2022 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
11413334
August 16, 2022
‌
US Patent 9889181 Bacteriophage lysin and antibiotic combinations against gram positive bacteria

Patent 9889181 was granted and assigned to Contrafect on February, 2018 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
9889181
February 13, 2018
‌
US Patent 10988520 Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Patent 10988520 was granted and assigned to Contrafect on April, 2021 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
10988520
April 27, 2021
‌
US Patent 9499594 Biofilm prevention, disruption and treatment with bacteriophage lysin

Patent 9499594 was granted and assigned to Contrafect on November, 2016 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
9499594
November 22, 2016
‌
US Patent 10744189 Lysin polypeptides active against Gram-negative bacteria

Patent 10744189 was granted and assigned to Contrafect on August, 2020 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
10744189
August 18, 2020
‌
US Patent 10851401 Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
10851401
December 1, 2020
‌
US Patent 10813983 Bacteriophage lysin and antibiotic combinations against gram positive bacteria

Patent 10813983 was granted and assigned to Contrafect on October, 2020 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
10813983
October 27, 2020
‌
US Patent 9718875 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy

Patent 9718875 was granted and assigned to Contrafect on August, 2017 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
9718875
August 1, 2017
‌
US Patent 11773140 Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serum

Patent 11773140 was granted and assigned to Contrafect on October, 2023 by the United States Patent and Trademark Office.

Contrafect
Contrafect
Contrafect
Contrafect
United States Patent and Trademark Office
United States Patent and Trademark Office
11773140
October 3, 2023
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us